Atlas Trials

The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum

Clinical trial NCT03010072 · COMPLETED

Trial details

NCT number
NCT03010072
Sponsor
Prim. Priv. Doz. Dr. Daniel Cejka
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endstage Renal Disease
Start date
2017-06-09
Primary completion
2018-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.